Lansoprazole Supplier-Buyer Network — Trade Flow Analysis

Name: Lansoprazole Supplier-Buyer Trade Network Dataset — 316+ Indian Exporters, 17+ Importers, 105+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Lansoprazole supplier network, Lansoprazole buyers, pharmaceutical export India, Lansoprazole trade data

TransData Nexus

Lansoprazole

India Pharmaceutical Trade Intelligence

$290.2M316 Suppliers105 CountriesHS 30049034

ExportsIndia → CANADA54.9%India → UNITED STATES20.7%

ImportsISRAEL → India$8.3M UNITED STATES → India$178.0K

#1 Supplier: SANDOZ PRIVATE #1 Buyer: SANDOZ CANADA

Who Supplies Lansoprazole? Top Manufacturers & Buyers 2026 — SANDOZ PRIVATE LIMITED Leads | TransData Nexus | TransData Nexus

1SANDOZ PRIVATE LIMITED

SANDOZ PRIVATE LIMITED is the first-largest Lansoprazole exporter from India, with a market share of 54.2% and a total export value of $157.4M across 69 shipments. Their average shipment value of $2.3M is above the market average of $59.6K, suggesting premium or bulk contract pricing.

SANDOZ PRIVATE LIMITED serves 5 named buyers in our database. SANDOZ CANADA INC. is the dominant customer, accounting for 99.3% of this supplier's tracked business. Top customers include:

• SANDOZ CANADA INC. — $156.3M across 68 shipments (99.3% of this supplier's total exports)

• SANDOZ CANADA INC. — $729.1K across 0 shipments (0.5% of this supplier's total exports)

• LEK D.D — $204.6K across 0 shipments (0.1% of this supplier's total exports)

• SANDOZ CANADA INC. — $144.8K across 0 shipments (0.1% of this supplier's total exports)

• Lek D D — $66.5K across 0 shipments (0.0% of this supplier's total exports)

Key Insight: SANDOZ PRIVATE LIMITED's per-shipment value of $2.3M is 3726% above the market average of $59.6K, consistent with large-order contracts or value-added formulations.

2MYLAN LABORATORIES LIMITED

MYLAN LABORATORIES LIMITED is the second-largest Lansoprazole exporter from India, with a market share of 6.3% and a total export value of $18.3M across 416 shipments. Their average shipment value of $43.9K is below the market average of $59.6K, reflecting a high-volume, competitive pricing strategy.

MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. MYLAN PHARMACEUTICALS INC is the dominant customer, accounting for 63.5% of this supplier's tracked business. Top customers include:

• MYLAN PHARMACEUTICALS INC — $11.6M across 264 shipments (63.5% of this supplier's total exports)

• MYLAN IRELAND C/O ALLOGA RDC, — $2.8M across 64 shipments (15.5% of this supplier's total exports)

• CSP VIATRIS SANTE AT CSP- LAB, — $2.2M across 50 shipments (12.1% of this supplier's total exports)

• CSP VIATRIS SANTE AT CSP- LAB, — $827.1K across 19 shipments (4.5% of this supplier's total exports)

• MYLAN PHARMACEUTICALS INC — $818.6K across 19 shipments (4.5% of this supplier's total exports)

Key Insight: MYLAN LABORATORIES LIMITED operates with high shipment frequency (416 shipments) at a per-shipment value of $43.9K, indicating a broad distribution network with many smaller, regular orders.

3PAR FORMULATIONS PRIVATE LIMITED

PAR FORMULATIONS PRIVATE LIMITED is the third-largest Lansoprazole exporter from India, with a market share of 5.5% and a total export value of $15.9M across 95 shipments. Their average shipment value of $167.0K is above the market average of $59.6K, suggesting premium or bulk contract pricing.

PAR FORMULATIONS PRIVATE LIMITED serves 4 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• UPS SUPPLY CHAIN SOL — $6.5M across 39 shipments (40.9% of this supplier's total exports)

• UPS SUPPLY CHAIN SOL — $5.9M across 36 shipments (37.5% of this supplier's total exports)

• UPS SUPPLY CHAIN SOL — $2.4M across 14 shipments (15.2% of this supplier's total exports)

• UPS SUPPLY CHAIN SOL — $1.0M across 6 shipments (6.5% of this supplier's total exports)

Key Insight: PAR FORMULATIONS PRIVATE LIMITED's per-shipment value of $167.0K is 180% above the market average of $59.6K, consistent with large-order contracts or value-added formulations.

4LINCOLN PHARMACEUTICALS LTD

LINCOLN PHARMACEUTICALS LTD is the fourth-largest Lansoprazole exporter from India, with a market share of 5.0% and a total export value of $14.5M across 34 shipments. Their average shipment value of $427.9K is above the market average of $59.6K, suggesting premium or bulk contract pricing.

LINCOLN PHARMACEUTICALS LTD serves 4 named buyers in our database. HEKO PHARMACY LTD is the dominant customer, accounting for 94.5% of this supplier's tracked business. Top customers include:

• HEKO PHARMACY LTD — $13.8M across 32 shipments (94.5% of this supplier's total exports)

• UNIVERSAL CO. LTD. — $745.5K across 2 shipments (5.1% of this supplier's total exports)

• AMIPHARMA LABORATORI — $43.2K across 0 shipments (0.3% of this supplier's total exports)

• INDIES PHARMA JAMACI — $7.2K across 0 shipments (0.0% of this supplier's total exports)

Key Insight: LINCOLN PHARMACEUTICALS LTD's per-shipment value of $427.9K is 618% above the market average of $59.6K, consistent with large-order contracts or value-added formulations.

5CAPLIN POINT LABORATORIES LIMITED

CAPLIN POINT LABORATORIES LIMITED is the fifth-largest Lansoprazole exporter from India, with a market share of 2.8% and a total export value of $8.0M across 128 shipments. Their average shipment value of $62.7K is above the market average of $59.6K, suggesting premium or bulk contract pricing.

CAPLIN POINT LABORATORIES LIMITED serves 5 named buyers in our database. NUEVOS ETICOS NEOETHICALS, S.A. is the dominant customer, accounting for 90.2% of this supplier's tracked business. Top customers include:

• NUEVOS ETICOS NEOETHICALS, S.A. — $7.2M across 115 shipments (90.2% of this supplier's total exports)

• BALGUERIE — $324.6K across 5 shipments (4.0% of this supplier's total exports)

• NUEVOS ETICOS NEOETHICALS, S.A. — $186.3K across 3 shipments (2.3% of this supplier's total exports)

• NUEVOS ETICOS NEOETHICALS, S.A. — $163.1K across 3 shipments (2.0% of this supplier's total exports)

• BALGUERIE RUE BERTRA — $110.9K across 2 shipments (1.4% of this supplier's total exports)

Key Insight: CAPLIN POINT LABORATORIES LIMITED's per-shipment value of $62.7K is 5% above the market average of $59.6K, consistent with large-order contracts or value-added formulations.

6CIPLA LIMITED

CIPLA LIMITED is the fifth-largest Lansoprazole exporter from India, with a market share of 1.7% and a total export value of $5.0M across 267 shipments. Their average shipment value of $18.7K is below the market average of $59.6K, reflecting a high-volume, competitive pricing strategy.

CIPLA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• CAPITAL PHARMACY — $1.6M across 84 shipments (31.6% of this supplier's total exports)

• MEDPRO PHARMACEUTICA (PTY) LTD. — $1.0M across 56 shipments (21.0% of this supplier's total exports)

• MEDPRO PHARMACEUTICA (PTY) LTD. — $992.7K across 53 shipments (19.9% of this supplier's total exports)

• ABACUS PHARMA LTD — $839.1K across 45 shipments (16.8% of this supplier's total exports)

• MEDPRO PHARMACEUTICA (PTY) LTD. — $529.3K across 28 shipments (10.6% of this supplier's total exports)

Key Insight: CIPLA LIMITED operates with high shipment frequency (267 shipments) at a per-shipment value of $18.7K, indicating a broad distribution network with many smaller, regular orders.

1Canada

Canada ranks as the first-largest destination for Lansoprazole imports from India, with a total trade value of $159.4M across 49 shipments — representing a 54.9% share of all Lansoprazole exports. The average shipment value of $3.3M is above the global average of $59.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Lansoprazole importers in Canada: SANDOZ CANADA INC. is the largest buyer, accounting for 98.5% ($157.0M) of this market's total imports.

• SANDOZ CANADA INC. — $157.0M (98.5% of Canada's total)

• SANDOZ CANADA INC — $1.5M (0.9% of Canada's total)

Key Insight: Canada's per-shipment average of $3.3M (5355% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Canada is a key market for Lansoprazole imports from India.

Primary Market

Secondary Market

2United States

United States ranks as the second-largest destination for Lansoprazole imports from India, with a total trade value of $60.2M across 132 shipments — representing a 20.7% share of all Lansoprazole exports. The average shipment value of $455.8K is above the global average of $59.6K, indicating high-value procurement contracts or branded formulations. This market is served by 5 tracked buyers.

Named Lansoprazole importers in United States: MYLAN PHARMACEUTICALS INC, is the largest buyer, accounting for 19.9% ($12.0M) of this market's total imports.

• MYLAN PHARMACEUTICALS INC, — $12.0M (19.9% of United States's total)

• EVERSANA LIFE SCIENCE SERVICES — $7.9M (13.0% of United States's total)

• RISING PHARMA HOLDINGS INC — $1.7M (2.8% of United States's total)

Key Insight: United States's per-shipment average of $455.8K (665% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Lansoprazole imports from India.

Primary Market

Secondary Market

3Tanzania

Tanzania ranks as the third-largest destination for Lansoprazole imports from India, with a total trade value of $14.6M across 14 shipments — representing a 5.0% share of all Lansoprazole exports. The average shipment value of $1.0M is above the global average of $59.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Lansoprazole importers in Tanzania: HEKO PHARMACY LTD is the largest buyer, accounting for 95.0% ($13.9M) of this market's total imports.

• HEKO PHARMACY LTD — $13.9M (95.0% of Tanzania's total)

Key Insight: Tanzania's per-shipment average of $1.0M (1650% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Tanzania is a key market for Lansoprazole imports from India.

Primary Market

Secondary Market

4France

France ranks as the fourth-largest destination for Lansoprazole imports from India, with a total trade value of $9.1M across 28 shipments — representing a 3.1% share of all Lansoprazole exports. The average shipment value of $323.6K is above the global average of $59.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Lansoprazole importers in France: CSP VIATRIS SANTE AT CSP- LAB, is the largest buyer, accounting for 24.3% ($2.2M) of this market's total imports.

• CSP VIATRIS SANTE AT CSP- LAB, — $2.2M (24.3% of France's total)

Key Insight: France's per-shipment average of $323.6K (443% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

France is a key market for Lansoprazole imports from India.

Primary Market

Secondary Market

5Guatemala

Guatemala ranks as the fifth-largest destination for Lansoprazole imports from India, with a total trade value of $8.3M across 55 shipments — representing a 2.9% share of all Lansoprazole exports. The average shipment value of $151.6K is above the global average of $59.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Lansoprazole importers in Guatemala: NUEVOS ETICOS NEOETHICALS, S.A. is the largest buyer, accounting for 90.4% ($7.5M) of this market's total imports.

• NUEVOS ETICOS NEOETHICALS, S.A. — $7.5M (90.4% of Guatemala's total)

Key Insight: Guatemala's per-shipment average of $151.6K (154% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Guatemala is a key market for Lansoprazole imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Lansoprazole.
2.Flow Mapping: 316 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 4,867 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 105 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

4,867 Verified Shipments

316 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Lansoprazole

Lansoprazole

Who Supplies Lansoprazole? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Lansoprazole? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Lansoprazole Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1SANDOZ PRIVATE LIMITED

2MYLAN LABORATORIES LIMITED

3PAR FORMULATIONS PRIVATE LIMITED

4LINCOLN PHARMACEUTICALS LTD

5CAPLIN POINT LABORATORIES LIMITED

6CIPLA LIMITED

From Indian Factories to Global Pharmacies — How Lansoprazole Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Lansoprazole Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Canada

2United States

3Tanzania

4France

5Guatemala

People Also Ask — Lansoprazole Supplier & Trade Network

Lansoprazole Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology